2025 annual financial data
Cytosorbents 2025 Operating margin
Cytosorbents 2025 operating margin with verified reported values.
Direct answer
Operating margin was -38.42%.
Operating income was -14,239,000 USD and net income was -8,198,000 USD.
Operating cash flow was -12,377,000 USD.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,063,000 USD
- Operating income
- -14,239,000 USD
- Net income
- -8,198,000 USD
- Operating cash flow
- -12,377,000 USD